number of downloads : ?
language
eng
Author
Akamatsu, Hiroaki Internal Medicine III, Wakayama Medical University, Wakayama, Japan
Ninomiya, Kiichiro Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
Kenmotsu, Hirotsugu Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan
Morise, Masahiro Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Aichi, Japan
Daga, Haruko Osaka City General Hospital, Osaka, Japan
Goto, Yasushi Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan
Kozuki , Toshiyuki Clinical Research Center, Department of Thoracic Oncology and Medicine, National Hospital Organization Shikoku Cancer Center, Ehime, Japan
Miura, Satoru Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan
Sasaki, Takaaki Respiratory Center, Asahikawa Medical University Hospital, Hokkaido, Japan
Tamiya, Akihiro National Hospital Organization Kinki-chuo Chest Medical Center, Osaka, Japan
Teraoka, Shunsuke Internal Medicine III, Wakayama Medical University, Wakayama, Japan
Yoshioka , Hiroshige Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan
Hattori, Yoshihiro Department of Thoracic Oncology, Hyogo Cancer Center, Hyogo, Japan
Imamura , Chiyo K. Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan
Katsuya, Yuki Department of Surgery, University of California San Diego, California, USA
Matsui, Reiko National Cancer Center Hospital East, Chiba, Japan
Minegishi, Yuji Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan
Mizugaki, Hidenori First Department of Medicine, Hokkaido University Hospital, Hokkaido, Japan
Nosaki, Kaname Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
Okuma, Yusuke Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan
Sakamoto, Setsuko Kyushu University Hospital, Fukuoka, Japan
Sone, Takashi Regional Respiratory Symptomatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
Tanaka, Kentaro Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
Umemura, Shigeki Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan
Yamanaka, Takeharu Department of Biostatistics, Yokohama City University School of Medicine, Kanagawa, Japan
Amano, Shinsuke Japan Federation of Cancer Patient Groups, Tokyo, Japan
Hasegawa, Kazuo Japan Lung Cancer Alliance, Tokyo, Japan
Morita, Satoshi Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan
Nakajima, Kazuko Shizuoka Cancer Center, Shizuoka, Japan
Maemondo, Makoto Division of Pulmonary Medicine, Allergry and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Iwate, Japan
Seto, Takashi Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
Yamamoto, Nobuyuki Internal Medicine III, Wakayama Medical University, Wakayama, Japan
Subject
Non-small cell lung cancer; Chemotherapy; Kinase inhibitor; Programed cell death-1 inhibitor; Programed death-ligand 1 inhibitor; Guideline
Journal Title
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
Volume
24
Issue
7
Start Page
731
End Page
770
ISSN
1341-9625
ISSN(Online)
1437-7772
Published Date
2019-07
DOI
PubMed ID
Publisher
SPRINGER JAPAN KK
NII Type
Journal Article
OAI-PMH Set
Faculty of Medicine
Remark
Preparation of these guidelines was funded by Japanese Lung Cancer Society. We did not receive any financial support from other organizations or companies.